Maintenance of platelet inhibition during antiplatelet therapy
US10744149B2 · kind B2 · utility
2Cited by
17References
47Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 18, 2019 |
| Grant date | Aug 18, 2020 |
| Priority date | — |
| Expiry date | Mar 18, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P7/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for reducing or maintaining platelet inhibition in a patient by administering cangrelor prior to an invasive procedure is described. The method of this invention can be used for patients in need of antiplatelet therapy or at risk of thrombosis. The method can further be used in patients who were previously treated with long-acting platelet inhibitors without increasing the risk of excessive bleeding.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.